Electrin-4 is a protein derived from Litoria rubella (Desert tree frog), an amphibian species native to Australia. Recent taxonomic research has revealed that the Litoria rubella species complex is distributed across much of continental Australia, southern New Guinea, and the Tanimbar Islands of Indonesia, inhabiting various environments from deserts to tropical forests. Molecular genetic analyses have identified four distinct lineages within this complex, with three new species recently recognized: L. rubella sensu stricto, L. pyrina sp. nov., and L. larisonans sp. nov. For research purposes, it's important to verify the specific lineage source of your Electrin-4 sample, as genetic variations between these newly identified species might affect protein characteristics.
Recombinant Litoria rubella Electrin-4 (UniProt accession number: P82100) is characterized by its short amino acid sequence FITVH, comprising only 5 amino acid residues (expression region 1-5) . The protein is typically produced in mammalian cell expression systems, resulting in a product with >85% purity as determined by SDS-PAGE analysis . The cytoplasmic domain constitution suggests potential membrane association or signaling functions, although comprehensive functional studies are still needed to elucidate its precise biological role.
For optimal stability of Recombinant Litoria rubella Electrin-4, storage at -20°C is recommended for regular use, while extended storage should be at -20°C or -80°C . Working aliquots should be stored at 4°C and used within one week. The shelf life varies based on formulation: liquid preparations typically maintain stability for approximately 6 months at -20°C/-80°C, while lyophilized preparations remain stable for up to 12 months under the same conditions . Critically, repeated freeze-thaw cycles significantly compromise protein integrity and should be strictly avoided; researchers should prepare appropriately sized single-use aliquots during initial reconstitution.
The recommended reconstitution protocol for Recombinant Litoria rubella Electrin-4 involves:
Brief centrifugation of the vial prior to opening to collect contents at the bottom
Reconstitution in deionized sterile water to achieve a concentration of 0.1-1.0 mg/mL
Addition of glycerol to a final concentration of 5-50% (with 50% being the standard recommendation)
Preparation of appropriately sized aliquots for long-term storage at -20°C/-80°C
This protocol helps maintain protein stability while minimizing degradation from repeated freeze-thaw cycles. For sensitive applications requiring higher purity, researchers may consider implementing additional purification steps such as size exclusion chromatography after reconstitution.
The expression system significantly influences the properties of recombinant proteins including Electrin-4. For Recombinant Litoria rubella Electrin-4, mammalian cell expression systems are typically employed , which provide advantages for proper protein folding and post-translational modifications compared to bacterial systems. When comparing with related proteins like Electrin-2.1, which can be produced in both E. coli and yeast expression systems , researchers should note that:
| Expression System | Advantages | Limitations | Applications |
|---|---|---|---|
| Mammalian (for Electrin-4) | More natural post-translational modifications; Better folding; Higher biological activity | Higher production cost; Longer production time | Functional studies; Structural analysis |
| E. coli (used for related proteins) | Higher yield; Lower cost; Faster production | Limited post-translational modifications; Potential improper folding | Antibody production; Preliminary screening |
| Yeast (used for related proteins) | Moderate post-translational processing; Higher yield than mammalian | Different glycosylation patterns than native | Protein-protein interaction studies |
The choice of expression system should be guided by the intended experimental application and required protein characteristics.
While specific purification protocols for Electrin-4 aren't detailed in the available data, the >85% purity achieved through SDS-PAGE analysis suggests effective purification methods are employed. For small peptides like Electrin-4 (sequence: FITVH), multi-step purification strategies would typically include:
Initial capture using affinity chromatography (based on the tag type determined during manufacturing)
Intermediate purification through ion-exchange chromatography
Polishing via size-exclusion chromatography or reversed-phase HPLC
The optimal purification strategy should be designed based on the specific tag utilized (which varies by manufacturing process ) and the required purity for intended applications. For applications demanding ultra-high purity (>95%), researchers may need to implement additional purification steps beyond the standard protocol.
Based on its properties and the broader context of amphibian-derived peptides, Recombinant Litoria rubella Electrin-4 may be valuable for:
Comparative structural studies of short peptides across amphibian species
Investigation of potential antimicrobial properties (common in amphibian-derived peptides)
Evolutionary studies examining the conservation of electrin proteins across the Litoria genus, particularly in light of recent taxonomic revisions identifying new species within the Litoria rubella complex
Development of novel peptide-based research tools or therapeutic candidates
Studies on peptide-membrane interactions, considering its cytoplasmic domain characteristics
Researchers should design appropriate controls when working with this peptide, particularly considering its short sequence (FITVH) which may exhibit non-specific interactions in certain experimental contexts.
Due to its small size (5 amino acids: FITVH), Electrin-4 may have limited immunogenicity on its own
For antibody development, conjugation to a carrier protein such as KLH or BSA may be necessary
The purity level (>85% by SDS-PAGE ) is sufficient for most immunization protocols, but potential contaminants should be considered when interpreting results
Cross-reactivity testing against related electrins (like Electrin-2.1 ) is advisable to ensure antibody specificity
When designing immunological experiments, researchers should consider the evolutionary context of Litoria rubella as a species complex with multiple lineages across Australia and surrounding regions , which may affect conservation of the target epitope across populations.
Given the small size of Electrin-4 (sequence: FITVH), appropriate analytical techniques for structure-function studies include:
Circular Dichroism (CD) spectroscopy to assess secondary structural elements
Nuclear Magnetic Resonance (NMR) spectroscopy for detailed 3D structural determination, particularly suitable for small peptides
Surface Plasmon Resonance (SPR) for binding kinetics analysis with potential interacting partners
Fourier-Transform Infrared Spectroscopy (FTIR) for complementary structural information
Molecular Dynamics (MD) simulations to predict conformational dynamics in different environments
The cytoplasmic domain characteristics of Electrin-4 suggest potential interactions with intracellular components or signaling pathways, which could be investigated using pull-down assays coupled with mass spectrometry to identify binding partners.
Comparative analysis between Electrin-4 (sequence: FITVH) and related proteins like Electrin-2.1 reveals interesting differences:
These differences suggest distinct evolutionary origins and potentially specialized functions that could be explored through comparative functional assays. Researchers investigating the electrin family should consider these differences when designing experiments or interpreting cross-reactivity in antibody-based studies.
Researchers studying Electrin-4 may encounter several methodological challenges:
The extremely short sequence (FITVH) presents difficulties in distinguishing specific from non-specific interactions
Limited literature specifically addressing Electrin-4 function necessitates extensive preliminary characterization
Recent taxonomic revisions in the Litoria rubella species complex raise questions about potential sequence variations across different populations
The cytoplasmic domain classification suggests potential membrane association, necessitating appropriate experimental systems for functional studies
Potential differences between recombinant and native forms, particularly if post-translational modifications are present in the native protein
To address these challenges, researchers should implement rigorous controls, consider using multiple complementary experimental approaches, and carefully validate findings across different experimental systems.
Integration of Electrin-4 research with broader amphibian peptide studies requires consideration of:
Evolutionary context: The recent taxonomic research revealing the Litoria rubella species complex comprises multiple distinct lineages provides an opportunity to examine electrin conservation and diversification across these evolutionary lines
Comparative functional analysis: Many amphibian-derived peptides possess antimicrobial, neuroactive, or other bioactive properties; researchers should test Electrin-4 in standardized assays used for these peptide classes
Ecological correlations: Considering that Litoria rubella inhabits diverse environments from deserts to tropical forests , correlation between habitat conditions and electrin properties could provide insights into adaptive functions
Integration with anatomical studies: Recent research on buccopharyngeal anatomy in Litoria rubella might offer context for electrin expression and function in specific tissues
This integrative approach would position Electrin-4 research within the broader framework of amphibian peptide biology, potentially revealing new insights into peptide evolution and functional diversification.
Before using Recombinant Litoria rubella Electrin-4 in experiments, researchers should verify:
Purity assessment: Confirm >85% purity by SDS-PAGE and consider additional analytical methods like mass spectrometry for sensitive applications
Sequence verification: For critical applications, sequence confirmation through mass spectrometry or Edman degradation is advisable
Tag presence and location: Determine the specific tag type used in manufacturing and assess its potential impact on experimental outcomes
Endotoxin levels: For cell-based assays, verify endotoxin levels are below thresholds that could confound results
Batch-to-batch consistency: When using multiple lots, compare key parameters to ensure experimental reproducibility
Documentation of these quality control evaluations should be maintained as part of standard laboratory practices to ensure data reproducibility and reliability.
When designing experiments with short peptides like Electrin-4 (sequence: FITVH), researchers should be aware of several potential pitfalls:
Non-specific binding: Short peptides may exhibit promiscuous binding, necessitating stringent controls and validation through multiple methods
Concentration-dependent aggregation: Monitor for potential aggregation at higher concentrations which can affect experimental outcomes
Buffer incompatibilities: Short peptides may be particularly sensitive to specific buffer components; optimization is essential
Adsorption to surfaces: Significant loss of peptide through adsorption to laboratory plasticware, requiring appropriate blocking or pre-treatment protocols
Detection challenges: The small size may present difficulties for standard detection methods, requiring optimization of detection protocols
To mitigate these challenges, researchers should include appropriate controls, validate findings through complementary methods, and carefully optimize experimental conditions for the specific properties of Electrin-4.
When encountering inconsistent results with Electrin-4, researchers should implement a systematic troubleshooting approach:
Storage and handling assessment: Verify adherence to recommended storage conditions (-20°C/-80°C) and avoidance of repeated freeze-thaw cycles
Reconstitution protocol review: Confirm proper reconstitution in deionized sterile water to 0.1-1.0 mg/mL with appropriate glycerol concentration (5-50%)
Lot-to-lot variation analysis: Compare experimental outcomes across different lots, potentially requesting detailed certificates of analysis from the supplier
Experimental condition optimization: Systematically vary buffer conditions, incubation times, and detection methods to identify optimal parameters
Complementary methodologies: Employ multiple analytical approaches to validate findings and identify method-specific artifacts
Documentation of these troubleshooting steps and their outcomes can help identify the source of variability and establish more robust experimental protocols for future work with Electrin-4.